Johnson & Johnson increased its quarterly profit by 4.5%


The world's largest producer of health products, Johnson & Johnson, reported an increase in net profit in the third quarter by 4.6% in annual terms to 3 billion 934 million dollars. Adjusted earnings were 2 dollars 5 cents per share, while experts had predicted 2 dollars 3 cents per share. Revenues reached $20 billion 300 million, exceeding economists' estimates of $20 billion 100 million. The pharmaceutical division increased quarterly sales by 6.7%. Growth in sales of consumer goods was 1.8%. Sales of medical devices rose 0.2%.

The information and recommendations contained in this analytical document are published strictly for information purposes and are not considered as an offer to buy or sell the trading tools mentioned above and are not intended to motivate to perform certain transactions
Something went wrong